Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
colloid solution
plasma volume expander |
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alternativeTo |
albumin
gelatin solutions |
| gptkbp:amendedBy |
hydroxyethylation
|
| gptkbp:ATCCode |
gptkb:B05AA07
|
| gptkbp:brand |
Hespan
Hetastarch Pentastarch Tetrastarch Voluven |
| gptkbp:CASNumber |
gptkb:9005-27-0
|
| gptkbp:contraindication |
sepsis
renal impairment critical illness |
| gptkbp:derivedFrom |
starch
|
| gptkbp:eliminatedIn |
renal
|
| gptkbp:halfLife |
varies (hours to days depending on type)
|
| gptkbp:hasRegulatoryStatus |
restricted in EU
boxed warning in US |
| https://www.w3.org/2000/01/rdf-schema#label |
Hydroxyethylated starch
|
| gptkbp:molecularWeight |
varies (commonly 130-450 kDa)
|
| gptkbp:regulates |
gptkb:FDA
gptkb:EMA |
| gptkbp:riskFactor |
bleeding
anaphylactoid reactions kidney injury tissue storage |
| gptkbp:sideEffect |
pruritus
renal dysfunction coagulopathy |
| gptkbp:usedFor |
treatment of hypovolemia
|
| gptkbp:bfsParent |
gptkb:Hydroxyethyl_starch
|
| gptkbp:bfsLayer |
7
|